Literature DB >> 2161939

Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells.

S L Chen1, P Mounts.   

Abstract

Human papillomavirus type 6 (HPV-6) is the etiologic agent of genital warts and recurrent respiratory papillomatosis. We are investigating the mechanism by which this virus stimulates cell proliferation during infection. In this paper, we report that the E5a gene of HPV-6c, an independent isolate of HPV-11, is capable of transforming NIH 3T3 cells. The E5a open reading frame (ORF) was expressed under the control of the mouse metallothionein promoter in the expression vector pMt.neo.1, which also contains the gene for G418 resistance. Transfected cells were selected for G418 resistance and analyzed for a transformed phenotype. The transformed NIH 3T3 cells overgrew a confluent monolayer, had an accelerated generation time, and were anchorage independent. In contrast, E5a did not induce foci in C127 cells, but C127 cells expressing E5a did form small colonies in suspension. The presence of the 12-kilodalton E5a gene product in the transformed NIH 3T3 cells was shown by immunoprecipitation and was localized predominantly to nuclei by an immunoperoxidase assay. A mutation in the E5a ORF was engineered to terminate translation. This mutant was defective for transformation, demonstrating that translation of the E5a ORF is required for biological activity. This is the first demonstration of a transforming oncogene in HPV-6, and the differential activity of E5a in these two cell lines should facilitate future investigations on the mechanism of transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161939      PMCID: PMC249539          DOI: 10.1128/JVI.64.7.3226-3233.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Condyloma acuminatum - United States, 1966-1981.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1983-06-17       Impact factor: 17.586

2.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

3.  Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination.

Authors:  M D Biggin; T J Gibson; G F Hong
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

4.  Rearrangements of host and viral DNA in mouse cells transformed by simian virus 40.

Authors:  P Mounts; T J Kelly
Journal:  J Mol Biol       Date:  1984-08-15       Impact factor: 5.469

5.  Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx.

Authors:  P Mounts; K V Shah; H Kashima
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probe.

Authors:  K Peden; P Mounts; G S Hayward
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

7.  Identification of a second transforming region in bovine papillomavirus DNA.

Authors:  J T Schiller; W C Vass; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Characterization of human papillomavirus type 6b DNA isolated from an invasive squamous carcinoma of the vulva.

Authors:  M S Kasher; A Roman
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

10.  Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter.

Authors:  T Kanda; S Watanabe; K Yoshiike
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

View more
  27 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Biologic properties and nucleotide sequence analysis of human papillomavirus type 51.

Authors:  O Lungu; C P Crum; S Silverstein
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells.

Authors:  G Pecoraro; M Lee; D Morgan; V Defendi
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 4.  Human papillomavirus infection with particular reference to genital disease.

Authors:  C Sonnex
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

5.  Human papillomavirus genomics: past, present and future.

Authors:  Ariana Harari; Zigui Chen; Robert D Burk
Journal:  Curr Probl Dermatol       Date:  2014-03-13

6.  Characterization of human papillomavirus type 57b: transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses.

Authors:  J M Trujillo; T C Wu; P Mounts
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

7.  Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas.

Authors:  T P DiLorenzo; B M Steinberg
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Mutational analysis of human papillomavirus type 11 E5a oncoprotein.

Authors:  S L Chen; T Z Tsai; C P Han; Y P Tsao
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Characterization and analysis of human papillomaviruses of skin warts.

Authors:  S L Chen; Y P Tsao; J W Lee; W C Sheu; Y T Liu
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein.

Authors:  M Conrad; V J Bubb; R Schlegel
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.